Mesalamine for Inflammatory Bowel Disease: Recent Reappraisals

E-ISSN： 2212-4055|7|1|1-5

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.7, Iss.1, 2008-03, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease

By Patel Mayur M. Amin Avani F.

Pharmaceutical Development and Technology, Vol. 18, Iss. 2, 2013-04 ,pp. : 390-400

Informa Healthcare

Access to resources Recommend Favorite

Recent Indications and Methods of Surgery for Inflammatory Bowel Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 113-118

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the management of inflammatory bowel disease

By Irving Peter M

Clinical Medicine, Vol. 9, Iss. 6, 2009-12 ,pp. : 605-608

Royal College Of Physicians

Access to resources Recommend Favorite

Recent developments in inflammatory bowel disease therapy

By Murthy S. Flanigan A.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 695-715

Informa Healthcare

Access to resources Recommend Favorite

Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2110-2119

Bentham Science Publishers

Access to resources Recommend Favorite